What is MedTech Acquisition Corporation (MTAC)?

MedTech Acquisition Corporation (MTAC) is a stock in the Financial Services sector, Shell Companies industry. View full analysis on Stocks360.

What is the current price of MTAC?

The current price of MTAC is $11.34. Prices are updated in real time on Stocks360.

What is MTAC's price-to-earnings (PE) ratio?

MTAC's trailing twelve-month PE ratio is -8.66, based on current price and earnings per share data available on Stocks360.

What is MTAC's market capitalization?

MTAC's market capitalization is $83,856,919.00, placing it in the small-cap tier.

MedTech Acquisition Corporation (MTAC)

Stock analysis · NASDAQ · Financial Services · Shell Companies

$11.34

Market Cap

$83.86M

PE (TTM)

-8.66

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-0.02

Day Range

$8.96 – $12.83

52-wk Range

$8.43 – $12.83

Avg Volume

N/A

Volume

176.27K

MedTech Acquisition Corporation (MTAC) is a publicly traded company in the Financial Services sector. Latest price: $11.34. Market cap $83.86M. Trailing PE -8.66. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About MedTech Acquisition Corporation

MedTech Acquisition Corporation currently has no significant active business operations. The firm's stated intention is to pursue and finalize a business combination — which could involve a merger, stock exchange, asset acquisition, or other forms of corporate restructuring — with one or more enterprises in the U.S. healthcare industry. Established in 2020, its corporate base is situated in Greenwich, Connecticut.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-8.66×
P/S (TTM)	1.86×
P/B	95.11×
PEG	0.07×
P/FCF (TTM)	-3.60×
EV / EBITDA	-6.93×
EV / Sales	1.60×
Earnings Yield	-8.94%
Free Cash Flow Yield	-27.76%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$71.99M
Revenue (TTM)	$45.08M
Net Income (TTM)	-$7.50M
Free Cash Flow (TTM)	-$20.94M
Net Debt	-$11.86M
Working Capital	$48.57M
Gross Margin	85.79%
Operating Margin	-67.68%
Net Margin	-123.59%
Return on Equity	540.49%
Return on Invested Capital	-59.21%